pre-IPO PHARMA

cessation-therapeutics PRESS RELEASE ARCHIVE

Jul 27, 2023

Cessation Therapeutics Announces Food and Drug Administration Authorization for First-in-Human Clinical Trial of Antibody for Prevention of Fentanyl Overdose


Feb 28, 2023

Cessation Therapeutics’ Anti-Fentanyl Monoclonal Antibody Treatment Shows Promise in Protecting Against Fentanyl-Induced Overdose


May 2, 2014

Research and Markets: Smoking Cessation Therapeutics Pipeline Review 2014 - Detailing 16 Companies and 25 Drug Profiles


Google Analytics Alternative